Literature DB >> 4014278

Changing pattern of infective endocarditis.

D Kaye.   

Abstract

There has been a significant trend toward an increase in the age of patients with endocarditis, and it seems likely that the age of these patients will continue to increase as the population ages. The proportion of patients with endocarditis who have rheumatic heart disease as an underlying lesion has decreased from about 40 percent in patients studied from 1950 to 1970 to about 25 percent in more recent series, and this trend will probably continue. Prosthetic valves and degenerative heart disease will undoubtedly become increasingly important underlying heart lesions in patients with endocarditis. Another large group of patients with infective endocarditis have no diagnosable underlying heart disease and comprise an increasing proportion of patients with endocarditis. Because of the aging of the population, more Streptococcus bovis and enterococcal endocarditis should be expected. With more prosthetic valves and with the aging of the population, more staphylococcal endocarditis should be anticipated. Economic forces will probably result in earlier discharge from the hospital, with either shorter courses of therapy or completion of therapy at home and perhaps more valve replacements.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014278     DOI: 10.1016/0002-9343(85)90378-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Brain magnetic resonance findings in infective endocarditis with neurological complications.

Authors:  Asako Azuma; Keiko Toyoda; Toshihiro O'uchi
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

Review 3.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

4.  Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.

Authors:  A S Bayer; J Tu
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 5.  Infective endocarditis during infancy and childhood: current status.

Authors:  S K Sanyal; M A Saleh; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 6.  Scintigraphic detection of inflammatory heart disease.

Authors:  A J Morguet; D L Munz; H Kreuzer; D Emrich
Journal:  Eur J Nucl Med       Date:  1994-07

7.  Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz.

Authors:  M Torres-Tortosa; M de Cueto; A Vergara; A Sánchez-Porto; E Pérez-Guzmán; M González-Serrano; J Canueto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 8.  Recognition, management and prophylaxis of endocarditis.

Authors:  D Stamboulian; E Carbone
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

9.  Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases.

Authors:  I Kupferwasser; H Darius; A M Müller; S Mohr-Kahaly; T Westermeier; H Oelert; R Erbel; J Meyer
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

10.  Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.

Authors:  M C Ramos; M L Grayson; G M Eliopoulos; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.